Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 1 of 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with “The Pink Sheet” DAILY to discuss pharma/biotech deal flow and secrets to the Bay Area’s biotech success.
You may also be interested in...
Nuvelo CEO Ted Love: An Interview With “The Pink Sheet” DAILY
A day after Nuvelo releases disappointing Phase III results for Bayer-partnered alfimeprase, Love discusses Nuvelo’s next steps for the thrombolytic, and other options in the company’s pipeline.
Nuvelo CEO Ted Love: An Interview With “The Pink Sheet” DAILY
A day after Nuvelo releases disappointing Phase III results for Bayer-partnered alfimeprase, Love discusses Nuvelo’s next steps for the thrombolytic, and other options in the company’s pipeline.
Bay Area Biotech Roundtable: What Does It Take To Excel In The Global Marketplace? (Part 2 of 3)
Avigen, Genomic Health, Nuvelo, Poniard and Rigel execs sit down with "The Pink Sheet" DAILY to discuss Asia, pharmacogenomics, and FDA's position on biomarkers.